These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34585675)

  • 1. Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating.
    Staller K; Hinson J; Kerstens R; Spalding W; Lembo A
    Am J Gastroenterol; 2022 Jan; 117(1):184-188. PubMed ID: 34585675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials.
    Chang L; Lembo AJ; Lavins BJ; Shiff SJ; Hao X; Chickering JG; Jia XD; Currie MG; Kurtz CB; Johnston JM
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1302-12. PubMed ID: 25312449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
    Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
    Brenner DM; Sharma A; Rao SSC; Laitman AP; Heimanson Z; Allen C; Sayuk GS
    Dig Dis Sci; 2024 May; 69(5):1731-1738. PubMed ID: 38594429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
    Lacy BE; Schey R; Shiff SJ; Lavins BJ; Fox SM; Jia XD; Blakesley RE; Hao X; Cronin JA; Currie MG; Kurtz CB; Johnston JM; Lembo AJ
    PLoS One; 2015; 10(7):e0134349. PubMed ID: 26222318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation.
    Daniali M; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2019 Dec; 20(17):2073-2080. PubMed ID: 31557072
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Outcomes Before and After Prucalopride Treatment: An Observational Study in Patients With Chronic Idiopathic Constipation in the United States.
    Lembo A; Cash BD; Lu M; Terasawa E; Terreri B; Du S; Ayyagari R; Feuerstadt P; Moshiree B; Westermeyer B; Pi S; Boules M
    Clin Transl Gastroenterol; 2024 May; 15(5):e00687. PubMed ID: 38357940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
    Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.
    Vigone B; Caronni M; Severino A; Bellocchi C; Baldassarri AR; Fraquelli M; Montanelli G; Santaniello A; Beretta L
    Arthritis Res Ther; 2017 Jun; 19(1):145. PubMed ID: 28633671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
    Coremans G; Kerstens R; De Pauw M; Stevens M
    Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
    Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.
    Ke M; Zou D; Yuan Y; Li Y; Lin L; Hao J; Hou X; Kim HJ
    Neurogastroenterol Motil; 2012 Nov; 24(11):999-e541. PubMed ID: 22882724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study.
    Dehury S; Mohapatra S; Das HS; Goutam S; Kaushik C
    Indian J Pharmacol; 2023; 55(1):6-13. PubMed ID: 36960515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
    Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
    Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.